GHK-Cu vs BPC-157: A Research Compound Comparison

GHK-Cu and BPC-157 are sometimes considered together in tissue-research contexts, but they are very different molecules. This is a neutral, structural comparison for Australian researchers. It does not discuss human use; Argon Peptides supplies both strictly for in-vitro research.

Structure

GHK-Cu is a copper-binding tripeptide — just three amino acids (glycine-histidine-lysine) complexed with a copper(II) ion. BPC-157 is a synthetic pentadecapeptide of fifteen amino acids with no metal complex. They share no sequence and have very different molecular weights.

• GHK-Cu: a three-amino-acid copper-binding tripeptide complex
• BPC-157: a fifteen-amino-acid synthetic pentadecapeptide
• Different sequences, different molecular weights, GHK-Cu carries a copper ion
• Both supplied as lyophilised powders for the laboratory

Pathways studied

Their different chemistry means they are studied against different mechanisms. GHK-Cu is examined in the literature largely in the context of copper transport and matrix/remodelling-related signalling in in-vitro models. BPC-157 is studied across a separate set of growth-factor and nitric-oxide-related pathways. For a researcher, the takeaway is that they are not substitutes for one another.

Laboratory handling

Both arrive lyophilised and are reconstituted in the laboratory with bacteriostatic or sterile water. As always, reproducible work depends on independently tested material with a Certificate of Analysis you can review before ordering.